MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgro...

por Greer, Yoshimi Endo, Gilbert, Samuel F., Gril, Brunilde, Narwal, Rajesh, Peacock Brooks, Danielle L., Tice, David A., Steeg, Patricia S., Lipkowitz, Stanley
Publicado 2019